Evogene (EVGN) Reports Q3 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.16), versus ($0.19) reported last year. Revenue for the quarter came in at $97 thousand, versus $367 thousand reported last year.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evogene Reports Second Quarter and First Half 2026 Financial Results
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Accuray (ARAY) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
